Building on our unique history of helping to commercialize technology out of Dartmouth College, Borealis works with academic researchers and other entrepreneurs around the world to bring healthcare innovations to market. Our healthcare portfolio comprises companies accelerating the development of life-changing therapies and improving healthcare delivery. We focus on life science platforms relating to drug discovery, delivery, and manufacturing and digital health companies that improve access and quality while lowering costs.
Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the [...]
Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing [...]
Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who [...]
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Boehringer Ingelheim (BI). Under the terms of the agreement, Adimab will use [...]
"I’ve worked with Borealis on multiple startups, including Adimab and Compass, and can attest to the firm’s crucial role in helping Dartmouth entrepreneurs build their companies as the trusted and local early-stage investor. The Borealis team are dedicated and thoughtful partners who align themselves with founders and support their vision."
Co-Founder, Adimab and Compass Therapeutics
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.